What is Smith+Nephew CORI?

Smith+Nephew CORI: handheld imageless orthopedic archetype

Smith+Nephew CORI is a handheld imageless orthopedic surgical robotic system from Smith+Nephew (LSE: SN / NYSE: SNN). Per DEPLOY's surgical cluster framework, CORI anchors the handheld imageless orthopedic archetype within the surgical cluster's Wave 3 orthopedic sub-cohort triangle alongside Stryker Mako (large-footprint CT-based) and Zimmer Biomet ROSA (mid-size cross-domain).

Smith+Nephew: LSE: SN / NYSE: SNN

Smith+Nephew is a publicly-traded medical-technology company dual-listed: LSE: SN (London) / NYSE: SNN (US). The UK + US dual-listing positions Smith+Nephew within both the UK + US medical-technology industrial-base layers; the company operates substantial orthopedic + wound-care + sports-medicine product portfolios beyond the CORI orthopedic-robotic vehicle.

Acquisition lineage: Blue Belt 2015 → Navio → CORI 2020

Per Agent A orthopedic ingest, the CORI lineage operates through a multi-stage acquisition + product evolution:

• Blue Belt Technologies acquired 2015: Smith+Nephew acquired Blue Belt Technologies, integrating handheld imageless orthopedic-robotic technology.
• Navio (intermediate): Blue Belt's Navio handheld robotic system continued under Smith+Nephew ownership.
• CORI 2020: rebranded/evolved as CORI Surgical System; current commercial generation.

Per DEPLOY's framework, the multi-stage lineage matters editorially at the entity verification layer: trade-press coverage framing CORI as a Smith+Nephew-native product without the Blue Belt + Navio lineage operates outside Agent A primary-source-anchored verification. The acquisition + evolution lineage is the load-bearing primary-source verification anchor.

FDA-cleared: total + partial + revision KNEE

Per Agent A orthopedic ingest, CORI is FDA-cleared for knee procedures:

• Total knee: cleared.
• Partial knee: cleared.
• Revision knee: cleared.

Per DEPLOY's framework, the knee-only robotic clearance scope matters editorially in contrast to multi-procedure cohort entries: Mako cleared multi-procedure (knee + hip + spine + shoulder); ROSA cleared cross-domain (knee + hip + brain + shoulder). CORI's knee-only robotic scope is the load-bearing FDA-clearance-posture framing.

CRITICAL HONESTY DISTINCTION: hip is NAVIGATION-ONLY, NOT robotic

Per Agent A orthopedic ingest, the CORI hip indication requires precise scoping: hip is NAVIGATION-ONLY, NOT robotic. Common aggregator confusion blurs this distinction by listing CORI hip alongside CORI knee in robotic-procedure scope. Per cap-flag-as-trust-signal, the navigation-vs-robotic hip distinction is a critical honesty cap-flag:

• CORI knee: ROBOTIC; full handheld robotic-assist execution.
• CORI hip: NAVIGATION-ONLY; tracking + planning support without robotic execution; the surgeon performs the hip procedure manually with navigation guidance.

Per DEPLOY's framework, the navigation-vs-robotic distinction matters editorially at the FDA-clearance verification layer: trade-press coverage framing CORI as "robotic knee + hip" operates outside Agent A primary-source-anchored verification. The navigation-only hip framing is the load-bearing primary-source verification posture; the knee-only robotic framing preserves cohort-framework boundary against the multi-procedure-robotic claims of Mako + ROSA.

Handheld imageless architecture (distinct from Mako large-footprint CT)

Per Agent A orthopedic ingest, CORI operates a handheld imageless architecture structurally distinct from large-footprint CT-based alternatives:

• CORI (handheld imageless): handheld robotic-assist device used intra-op; NO pre-operative CT imaging required; intra-op anatomy registration replaces pre-op CT planning.
• Mako (large-footprint CT-based): pre-operative CT imaging informs patient-specific implant + cut plan; large-footprint robotic arm for intra-op execution.

Per DEPLOY's framework, the handheld imageless vs large-footprint CT-based architectural distinction is editorial signal at the cohort-architecture layer: imageless-handheld enables smaller-footprint OR integration + lower-imaging-prep workflow; CT-based enables patient-specific planning depth + larger-footprint robotic execution. The orthopedic sub-cohort form-factor variance is a load-bearing structural axis.

AI-augmented surgeon-controlled assistance (NOT autonomous); same class as Mako + da Vinci + ROSA

Per Agent A orthopedic ingest + DEPLOY's surgical cluster framework, CORI operates AI-augmented surgeon-controlled assistance, NOT autonomous-robotic surgery: same assistive class as Mako + Intuitive da Vinci + Moon Maestro + ROSA. The AI-augmented-not-autonomous framing is applied consistently across the orthopedic sub-cohort triangle and across the broader surgical cluster.

Per DEPLOY's framework, the consistent framing matters editorially: trade-press coverage framing orthopedic-robotic systems as "autonomous surgical robots" operates outside Agent A primary-source-anchored verification. The cohort-framework discipline preserves the assistive-vs-autonomous distinction across all surgical-robotic anchors.

Cohort positioning: handheld imageless orthopedic archetype

Per the surgical cluster framework, Smith+Nephew CORI anchors:

• Handheld imageless orthopedic archetype: handheld intra-op device + imageless workflow; smaller-footprint OR integration; commercial-niche positioning.
• Wave 3 orthopedic sub-cohort triangle: Mako (large-footprint CT-based) + CORI (handheld imageless) + ROSA (mid-size cross-domain); form-factor variance axis.
• Knee-only robotic scope + navigation-only hip honesty distinction: critical FDA-clearance precision; consistent application of verified-vs-claimed framework.
• Blue Belt 2015 → Navio → CORI 2020 lineage: multi-stage acquisition + product evolution within Smith+Nephew portfolio.
• AI-augmented-surgeon-controlled-not-autonomous: consistent framing across orthopedic sub-cohort + broader surgical cluster.

Contrast with cohort:

• Stryker Mako: large-footprint CT-based; multi-procedure (knee + hip + spine + shoulder); market-leader positioning.
• Zimmer Biomet ROSA: mid-size cross-domain (knee + hip + brain + shoulder).
• Intuitive da Vinci: replacement-robotics soft-tissue market-leader.
• Moon Surgical Maestro: assistive-laparoscopy commercial-niche.
• CMR Versius: international commercial soft-tissue modular architecture.

Consumer pricing surface for Smith+Nephew CORI is forthcoming via Agent B's planned orthopedic sub-cohort /price triangle; per cap-flag-as-trust-signal, the consumer-price-page is documented as forthcoming honest-absence pending Agent B's ship. Registry institutional depth at Smith+Nephew registry company + CORI registry model.

For the canonical surgical cluster context, see the surgical robotics cluster. For the large-footprint CT-based contrast, see what is Stryker Mako. For the mid-size cross-domain contrast, see what is Zimmer Biomet ROSA. For the canonical category umbrella, see what is physical AI. For methodology canonical references applicable to Smith+Nephew CORI: the 4-way autonomy-boundary taxonomy (AI-augmented operator-controlled tier; handheld imageless variant) + verified-vs-claimed at within-entity granularity (CRITICAL HONESTY DISTINCTION: hip is NAVIGATION-ONLY NOT robotic; within-entity per-procedure scope) + the 9-tier source-quality rubric (FDA + Smith+Nephew SEC source classification).